TABLE 2.
Specimen type (no. of specimens) [no. of MRSA] | Medium | Sensitivity (%) after incubation for:
|
Specificity (%) after incubation for:
|
||
---|---|---|---|---|---|
18-24 h | 48 h | 18-24 h | 48 h | ||
Overall (6,199) [181] | MRSA Select | 93a | 98b | 99.5 | 92a |
Mannitol-salt agar with cefoxitin | 69a | 90b | 92 | 78a | |
Catheter exit site samples (647) [14] | MRSA Select | 100 | 100 | 99.8 | 97 |
Mannitol-salt agar with cefoxitin | 50 | 86 | 98 | 90 | |
Nares swabs (2,483) [57] | MRSA Select | 90 | 97 | 99.6 | 93 |
Mannitol-salt agar with cefoxitin | 70 | 95 | 97 | 89 | |
Perianal/rectal swabs (2,312) [64] | MRSA Select | 97 | 100b | 99.3 | 90 |
Mannitol-salt agar with cefoxitin | 66 | 86b | 85 | 58 | |
Sputum samples (58) [4] | MRSA Select | 100 | 100 | 100 | 94 |
Mannitol-salt agar with cefoxitin | 50 | 75 | 100 | 93 | |
Skin/soft tissue samples (632) [42] | MRSA Select | 91 | 95 | 99.5 | 95 |
Mannitol-salt agar with cefoxitin | 81 | 93 | 96 | 85 |
The values are significantly different for the two media (P < 0.0001).
The values are significantly different for the two media (P = 0.003).